tiprankstipranks
Trending News
More News >
Novo Nordisk (DE:NOV)
XETRA:NOV
Germany Market

Novo Nordisk (NOV) Technical Analysis

Compare
334 Followers

Summary of all the Indicators

Overall Consensus
Sell
6Bullish
6Neutral
10Bearish
Technical Analysis Consensus
Neutral
2Bullish
6Neutral
2Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
Novo Nordisk’s (NOV) Moving Averages Convergence Divergence (MACD) indicator is -0.87, suggesting Novo Nordisk is a Sell.
Novo Nordisk’s (NOV) 20-Day exponential moving average is 58.71, while Novo Nordisk’s (NOV) share price is €58.72, making it a Buy.
Novo Nordisk’s (NOV) 50-Day exponential moving average is 63.36, while Novo Nordisk’s (NOV) share price is €58.72, making it a Sell.

Novo Nordisk (NOV) Pivot Points

May 17, 2025, 04:47 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
54.72
56.20
57.06
58.54
59.40
60.88
61.74
Fibonacci
56.20
57.10
57.65
58.54
59.44
59.99
60.88
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Novo Nordisk (NOV) Moving Averages

May 17, 2025, 04:47 AM
Period
Simple
Exponential
MA5
58.84Sell
58.66Buy
MA10
59.27Sell
58.55Buy
MA20
57.29Buy
58.71Buy
MA50
63.09Sell
63.36Sell
MA100
72.01Sell
72.23Sell
MA200
90.20Sell
88.53Sell
Novo Nordisk’s (NOV) 10-Day exponential moving average is 58.55, while Novo Nordisk’s (NOV) share price is €58.72, making it a Buy.
Novo Nordisk’s (NOV) 100-Day exponential moving average is 72.23, while Novo Nordisk’s (NOV) share price is €58.72, making it a Sell.
Novo Nordisk’s (NOV) stock price is €58.72 and Novo Nordisk’s (NOV) 50-day simple moving average is 63.09, creating a Sell signal.
Novo Nordisk’s (NOV) stock price is €58.72 and Novo Nordisk’s (NOV) 100-day simple moving average is 72.01, creating a Sell signal.
Novo Nordisk’s (NOV) stock price is €58.72 and Novo Nordisk’s (NOV) 200-day simple moving average is 90.20, creating a Sell signal.

Novo Nordisk (NOV) Technical Indicators

May 17, 2025, 04:47 AM
Name
Value
Implied Action
RSI (14)
47.77
Neutral
STOCH (9,6)
42.85
Neutral
STOCHRSI (14)
53.63
Neutral
MACD (12,26)
-0.87
Sell
ADX (14)
21.44
Neutral
Williams %R
-43.19
Buy
CCI (14)
31.44
Neutral
ATR (14)
2.78
-
Ultimate Oscillator
49.57
Neutral
ROC
6.84
Buy
Novo Nordisk’s (NOV) Relative Strength Index (RSI) is 47.77, creating a Neutral signal.
Novo Nordisk’s (NOV) Trend Strength Indicator (ADX) is 21.44, creating a Neutral signal.
Novo Nordisk’s (NOV) Commodity Channel Index (CCI) is 31.44, creating a Neutral signal.
Novo Nordisk’s (NOV) Price Rate of Change (ROC) is 6.84, creating a Buy signal.

FAQ

Is NOV a Buy, Hold, or Sell?
Based on NOV’s technical indicators, NOV is a Sell.
    What is NOV’s RSI (14)?
    NOV’s RSI (14) is 47.77, which suggests NOV is a Neutral.
      What is NOV’s MACD?
      NOV’s MACD is -0.87, which suggests NOV is a Sell.
        What is NOV’s 5-day moving average?
        NOV’s 5-day moving average is 58.84, which suggests NOV is a Sell.
          What is NOV’s 20-day moving average?
          NOV 20-day moving average is 57.29, which suggests NOV is a Buy.
            What is NOV’s 50-day moving average?
            NOV’s 50-day moving average is 63.09, which suggests NOV is a Sell.
              What is NOV’s 200-day moving average?
              NOV’s 200-day moving average is 90.20, which suggests NOV is a Sell.
                What is NOV’s Williams % R (14)?
                NOV’s Williams % R (14) is -43.19, which suggests NOV is a Buy.
                  What is NOV’s CCI (14)?
                  NOV’s CCI (14) is 31.44, which suggests NOV is a Neutral.
                    What is the share price of Novo Nordisk?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis